Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




An Innovative GLIF Approach for Minimally Invasive Back Surgery

By HospiMedica staff writers
Posted on 27 Sep 2007
A novel guided lumbar interbody fusion (GLIF) system under development will allow surgeons to perform a 360-degree minimally invasive procedure without the need for a second incision or repositioning of the patient.

The new system is intended to reduce the length of the procedure, reduce the trauma to the patient, and reduce the post-surgery recovery period. More...
The GLIF system will provide a lateral approach to the spine with the patient in a natural, facedown position, which is intended to make interbody fusion and eventually disc replacement surgery faster and safer. The GLIF system will be developed and commercialized by Alphatec Spine (Carlsbad, CA, USA) under an exclusive worldwide license granted in an agreement with JGMG Bengochea (Jacksonville, FL, USA).

"The GLIF system is a shining example of Alphatec's focus on improving surgical efficacy with more advanced science,” said Dirk Kuyper, Alphatec's President and CEO.

Spinal fusions are indicated for patients with lower back and/or leg pain due to degenerative disc disease or instability. As the vertebra settle due to disc height loss, contact pressure on the posterior facets increases, which incites inflammation and pain. Currently, spinal fusion is the only proven surgical technique, which improves the pain of degenerative disc disease. In response to shortcomings of posterior spinal fusion, anterior and lateral fusion techniques are being developed.


Related Links:
Alphatec Spine

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.